View printer-friendly version

Download PDF

Emergent BioSolutions to Participate in Series of Investor Conferences

GAITHERSBURG, Md., May 20, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the second quarter of 2019:

RBC Capital Markets – 2019 Global Healthcare Conference
New York, NY
May 21-22, 2019

Goldman Sachs – 40th Annual Global Healthcare Conference (1×1 Meetings Only)
Rancho Palos Verdes, CA
June 11-13, 2019

Three Part Advisors – East Coast IDEAS Conference
Boston, MA
June 12-13, 2019

BMO – Prescriptions for Success Healthcare Conference 2019
New York, NY
June 25, 2019

Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats. We aspire to be a Fortune 500 company recognized for protecting and enhancing life, driving innovation, and living our values. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.